Clinical-MRI correlations in a European trial of interferon beta-1b in secondary progressive MS.

Abstract

BACKGROUND The recently completed placebo-controlled multicenter randomized trial of interferon beta-1b (Betaferon) in 718 patients with secondary progressive MS shows significant delay of disease progression and reduction of relapse rate. This study provides an opportunity to assess the level of relationship between clinical and MRI outcomes in this cohort… (More)

Topics

Cite this paper

@article{Molyneux2001ClinicalMRICI, title={Clinical-MRI correlations in a European trial of interferon beta-1b in secondary progressive MS.}, author={Paul David Molyneux and Gareth J Barker and Frederik Barkhof and Karola Beckmann and Frank Dahlke and Massimo Filippi and Mojgan Ghazi and D. Hahn and David G. MacManus and C H Polman and Carlo Pozzilli and Ludwig Kappos and Alan J. Thompson and Klaus F. Wagner and Tarek Yousry and D. H. Miller}, journal={Neurology}, year={2001}, volume={57 12}, pages={2191-7} }